Loading clinical trials...
Loading clinical trials...
Palbociclib Treatment Patterns in Swedish Patients With Metastatic Breast Cancer - Swedish Ibrance Registries Insights (SIRI)
Conditions
Interventions
palbociclib
Locations
1
Sweden
Pfizer Sweden
Sollentuna, Sweden
Start Date
December 15, 2020
Primary Completion Date
May 31, 2026
Completion Date
May 31, 2026
Last Updated
March 31, 2026
NCT07067138
NCT06878248
NCT04669873
NCT02204098
NCT03162627
NCT03165487
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions